Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
Aclaris Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 21, 2022
Aclaris Therapeutics reported fiscal year 2019 executive compensation information on April 21, 2022.
In 2019, four executives at Aclaris Therapeutics received on average a compensation package of $1.8M, a 36% decrease compared to previous year.
Average pay of disclosed executives at Aclaris Therapeutics
Neal Walker, Chief Executive Officer, received $3.2M in total, which decreased by 28% compared to 2018. 77% of Walker's compensation, or $2.4M, was in stock awards. Walker also received $204K in non-equity incentive plan, $500K in salary, as well as $12K in other compensation.
David Gordon, MB ChB, Chief Medical Officer, received a compensation package of $1.4M, which decreased by 35% compared to previous year. 61% of the compensation package, or $844K, was in stock awards.
David Gordon, Chief Medical Officer, earned $1.4M in 2019.
Frank Ruffo, Chief Financial Officer, received $1.2M in 2019.
Related executives
You may also like
Source: SEC filing on April 21, 2022.